MacroGenics to Participate in Upcoming Investor Conferences
ROCKVILLE, Aug. 05, 2021 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative…
Pharmaceuticals, Biotechnology and Life Sciences
ROCKVILLE, Aug. 05, 2021 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative…
NEW YORK, Aug. 05, 2021 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology…
Raises full year 2021 guidance and announces deal to acquire Pinnacle 21PRINCETON, N.J., Aug. 05, 2021 (GLOBE NEWSWIRE) — Certara,…
BUFFALO, N.Y., Aug. 05, 2021 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company…
Transaction expected to be accretive to Certara’s revenue, revenue growth and adjusted EBITDA marginPRINCETON, N.J., Aug. 05, 2021 (GLOBE NEWSWIRE)…
Second Quarter Net Revenue of $2.3 Million; 44% Year-Over-Year Increase; Strategic Acquisition of GenArraytion, Inc.; HDF Product Submitted to FDA…
– Approximately $7 Million in International Sales of Oral TPOXX® in the Second Quarter – – Authorization of Additional $50…
SOUTH SAN FRANCISCO, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company…
Collaboration will initially explore the therapeutic potential of a combination of Imugene’s CF33-CD19 oncolytic virus (onCARlytics) and Celularity’s CD19 targeting…
MELBOURNE, Australia, Aug. 04, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) announces today that the…